BofA raised the firm’s price target on Omega Healthcare (OHI) to $48 from $46 and keeps a Neutral rating on the shares. While stock performance did not reflect it, Q3 earnings season was “strong” for U.S. REITs as 69% of REITs beat the Street, the analyst tells investors in a note on the group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $45 from $42 at Scotiabank
- Omega Healthcare price target raised to $50 from $45 at Citi
- Omega Healthcare Investors Reports Strong Q3 2025 Earnings
- Omega Healthcare Announces New $2 Billion Equity Offering
- Omega Healthcare: Strong Q3 Performance and Strategic Ventures Justify Buy Rating